Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow‐derived progenitor cells via the CXCR‐4/SDF‐1 axis

This publication has 44 references indexed in Scilit:

• G-CSF treatment after myocardial infarction: Impact on bone marrow—derived vs cardiac progenitor cells
  Experimental Hematology, 2008
• Effects of Granulocyte Colony Stimulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization
  Journal of the American College of Cardiology, 2006
• G‐CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis
  The FASEB Journal, 2006
• Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial InfarctionA Randomized Controlled Trial
  JAMA, 2006
• G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes
  Nature Medicine, 2005
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction
  Journal of the American College of Cardiology, 2004
• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
  Circulation, 2004
• Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
  The Lancet, 2003
• G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
  Nature Immunology, 2002